SHELLY COLLINS: Open Payments
NPI 1508275512 · MOBERLY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,876 in 84 payments from 21 companies in 2025. Trend: 2023 $1,191 · 2024 $2,151 · 2025 $1,876
Food & beverage: $1,876
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $502 |
| AstraZeneca Pharmaceuticals LP | 12 | $446 |
| Novo Nordisk Inc | 5 | $174 |
| Neurocrine BioSciences, Inc. | 5 | $120 |
| Viatris Specialty LLC | 6 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $106 |
| Radius Health, Inc. | 4 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Verona Pharma, Inc. | 2 | $31 |
Products named: BREZTRI, VRAYLAR, QULIPTA, AIRSUPRA, Wegovy, INGREZZA, YUPELRI, CAPLYTA.
Industry payments across MO — which companies pay providers there.
